References
Svedberg J, de Haas J, Liemenstoff G, Paul P, Teschemacher H (1985). Demonstration of B-casomorphin immunoreactive materials in In Vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 6, 825–830.
Chin-Dusting J, Shennan J, Jones E, Williams C, Kingwell B, Dart A (2006). Effect of dietary supplementation of beta casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease. Br J Nutr 95, 135–144.
Venn BJ, Skeaff CM, Brown R, Mann JI, Green TJ (2006). A comparison of the effects of A1 and A2 beta-casein protein variants on blood cholesterol concentrations in New Zealand adults. Atherosclerosis, in press.
Muntoni S, Muntoni S (2006). Epidemiological association between some dietary habits and the increasing incidence of type 1 diabetes worldwide. Ann Nutr Metab 50, 11–19.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Truswell, A. Reply: The A2 milk case: a critical review. Eur J Clin Nutr 60, 924–925 (2006). https://doi.org/10.1038/sj.ejcn.1602454
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602454
- Springer Nature Limited